Larvol Delta - Study-of-Eblasakimab-in-Male-or-Female-ModeratetoSevere-Atopic-Dermatitis-Patients-Previously-Treated-With-Dupilumab

Dupixent (dupilumab) - Sanofi, Regeneron

eblasakimab (ASLAN004) - ASLAN Pharma

http://clinicaltrials.gov/ct2/show/NCT05694884

Jan 23, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next